Research output per year
Research output per year
Search results
-
2018
Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407))
Shroff, R. T., Yarchoan, M., O'Connor, A., Gallagher, D., Zahurak, M. L., Rosner, G., Ohaji, C., Sartorius-Mergenthaler, S., Parkinson, R., Subbiah, V., Zinner, R. & Azad, N. S., Jan 1 2018, In: British journal of cancer. 118, 2, p. e2Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations